These results reminded that blockade of β-catenin signals to combine with chemotherapy could efficiently reverse the drugs resistance induced by ITGB1 and improved the anticancer effects, providing an innovative approach for gastric cancer therapy. The gene discussed is ITGB1; the disease is gastric cancer.